PR Newswire

Research highlights the use of multimodal machine learning to identify non-small cell lung cancer patients predicted to derive the most…

NEW YORK, Sept. 14, 2024 /PRNewswire/ -- International menswear brand Coofandy and women's sleepwear label Ekouaer made a bold entrance…

SAN DIEGO, Sept. 13, 2024 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or…

BEIJING, Sept. 14, 2024 /PRNewswire/ -- The educational project Jiangcun Academy aimed at inheriting and promoting the scholarly spirit of Chinese…

NANJING, China, Sept. 14, 2024 /PRNewswire/ -- On September 2, 2024, Simcere Pharmaceuticals Group Ltd. (2096.HK) announced that Sanbexin Sublingual Tablets…

In Phase Ia clinical study, GZR4 demonstrated favorable safety and tolerability profiles in healthy subjects, maintaining a stable glucose-lowering effect…

CHENGDU, China, Sept. 14, 2024 /PRNewswire/ -- With cross-border trade representing a new direction for e-commerce in recent years, cross-border…

ANAHEIM, Calif., Sept. 14, 2024 /PRNewswire/ -- At RE+ 2024, Sunwoda made a significant impact under the theme "Sunwoda Inside," underscoring…

HOUSTON, Sept. 14, 2024 /PRNewswire/ -- Sineng Electric, a global leader in solar and energy storage solutions, has officially inaugurated…

HANOI, Vietnam, Sept. 14, 2024 /PRNewswire/ -- Mox Capital, a trailblazer in alternative investments with AUM of US$1.4 billion, is…

Updated Phase 1 dose-escalation data from ARROS-1 and ALKOVE-1 clinical trials continue to support potential best-in-class profiles for zidesamtinib and…

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, Sept. 14, 2024 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical…